A Multi-center Evaluation of Aldafermin in a Randomized, Double-blind, Placebo-controlled Study in Subjects With Primary Sclerosing Cholangitis.
Clinical trial NCT06654726 · WITHDRAWN
Trial details
- NCT number
- NCT06654726
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2024-12-05
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.